Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astracytron Fito is a multi-ingredient dietary supplement developed and manufactured by the Ukrainian pharmaceutical company Astrapharm. It is formulated as a powder for oral solution in sachets, designed to support the immune system and promote the proper functioning of the upper respiratory tract, nasal cavity, and paranasal sinuses during cold and flu seasons. The supplement contains a combination of herbal extracts, including verbena extract (*Verbena officinalis*), black elderberry fruit extract (*Sambucus nigra*), mullein extract (*Verbascum thapsus*), ginger root extract (*Zingiber officinale*), and pelargonium root extract (*Pelargonium sidoides*), enriched with vitamin C (ascorbic acid) and menthol. These active ingredients work synergistically to provide anti-inflammatory, expectorant, mucolytic, antiviral, and antioxidant effects, helping to relieve nasal congestion, ease breathing, and reduce symptoms of intoxication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Astracytron Fito.